| Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis (NCT05492565) | Hospitales Universitarios Virgen del Rocío | 2020-01-01 |
| Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination (NCT03776760) | Kirby Institute | 2019-05-28 |
| Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines (NCT03410953) | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | 2018-04-13 |
| Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) (NCT02613403) | Merck Sharp & Dohme LLC | 2015-12-10 |
| Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002) (NCT01532973) | Merck Sharp & Dohme LLC | 2012-02-16 |
| Computer-Assisted Tailored Cue-card Health [CATCH] Study (NCT01170741) | RTI International | 2010-06-01 |
| A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area (NCT00913757) | National Cancer Institute (NCI) | 2009-07-01 |
| Epidemiological Study in Children and Adolescents With Chronic Hepatitis B (NCT01163240) | Novartis Pharmaceuticals | 2009-06-01 |
| Evaluation and Medico-Economic Study of FIBROSCAN in Patients With Viral Hepatitis (NCT00318682) | Assistance Publique - Hôpitaux de Paris | 2006-05-01 |
| Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin (NCT00230854) | OPKO Health, Inc. | 2005-08-01 |
| Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis (NCT00116454) | ANRS, Emerging Infectious Diseases | 2005-07-01 |
| Retrovirus Epidemiology Donor Study-II (REDS-II) (NCT00097006) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-09-01 |
| Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) (NCT00564811) | UPECLIN HC FM Botucatu Unesp | 2003-03-01 |
| Genes Involved in Resistance or Susceptibility to Hepatitis B Virus (NCT00342186) | National Cancer Institute (NCI) | 2002-09-27 |
| Transfusion Infections Pediatric Prospective Study (TRIPPS) (NCT00029406) | Naomi Luban | 2001-04-01 |
| Hepatitis C in Clinically Discordant Hemophilic Siblings (NCT00007371) | University of North Carolina, Chapel Hill | 1999-09-01 |
| Risk of Post Transfusion Hepatitis C Virus Infection (NCT00005339) | National Heart, Lung, and Blood Institute (NHLBI) | 1992-02-01 |
| Prospective Study of HIV Infection in Hemophiliacs (NCT00005309) | Bloodworks | 1990-07-01 |
| Natural History of Post-transfusion Non-A, Non-B Hepatitis (NCT00005306) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-03-01 |
| Hepatitis Delta Infections in Hemophiliacs (NCT00005305) | University of North Carolina, Chapel Hill | 1987-09-01 |
| Delta Hepatitis and Liver Disease in Hemophiliacs (NCT00005304) | Baylor College of Medicine | 1986-09-01 |
| Hepatitis B Vaccine Clinical Trial (NCT00000583) | National Heart, Lung, and Blood Institute (NHLBI) | 1978-11-01 |